Arbutus files patent infringement lawsuit against Pfizer/BioNTech (updated)

Arbutus Biopharma

04/04/2023 13:22

(Adds details, shares)
       April 4 (Reuters) - Arbutus Biopharma  ABUS.O  said on
Tuesday it has filed a lawsuit in the New Jersey district court
against Pfizer Inc  PFE.N  and BioNTech SE  BNTX.O , claiming
their mRNA COVID-19 vaccines infringe five of Arbutus' patents. 
    Arbutus, along with its licensee Genevant Sciences, is
seeking damages over the use of lipid nanoparticle (LNP)
delivery technology in Pfizer/BioNTech vaccines to carry and
deliver genetic material into the body.
    Pfizer and BioNTech did not immediately respond to Reuters'
requests for comment on the lawsuit.
    Shares of the Pennsylvania-based Arbutus rose marginally to
$3.09 before the bell. 
    
    
    

 (Reporting by Bhanvi Satija in Bengaluru; Editing by Krishna
Chandra Eluri)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))